Skip to search.
 FTSE 100 Up 1.82%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
7.07 Down 0.16(2.21%) 18:13 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:7.23
Open:7.16
Bid:7.06 x 600
Ask:7.07 x 100
1y Target Est:21.40
Beta:2.70706
Earnings Date:9 Nov - 13 Nov (Est.)
Day's Range:7.01 - 7.30
52wk Range:6.19 - 13.04
Volume:534,938
Avg Vol (3m):1,489,340
Market Cap:509.87m
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for INO at this time.

Comparison

Symbol% ChgMkt Cap
INODown 2.21%509.87m
PFEDown 0.17%196.83b
AZNUp 1.55%81.33b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.57
Quarterly EPS Est (Sep-15) :-0.04
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback